Breakthrough in Long COVID: An investigator-initiated trial (IIT) with Hyundai Bioscience's ...

Hyundai Bioscience collaborates with UCSD to trial Xafty, a niclosamide-based antiviral, for treating Long-COVID, aiming to address complex symptoms through multiple mechanisms.